Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

SELL
$191.89 - $259.92 $959 - $1,299
-5 Reduced 0.11%
4,755 $961,000
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $2,562 - $3,250
-13 Reduced 0.27%
4,760 $1.04 Million
Q3 2022

Nov 10, 2022

SELL
$182.44 - $250.54 $790,512 - $1.09 Million
-4,333 Reduced 47.58%
4,773 $939,000
Q2 2022

Aug 12, 2022

SELL
$204.13 - $302.4 $469,499 - $695,520
-2,300 Reduced 20.16%
9,106 $1.95 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $387,220 - $494,445
-1,102 Reduced 8.81%
11,406 $4.3 Million
Q3 2021

Nov 08, 2021

SELL
$372.64 - $458.3 $111,792 - $137,490
-300 Reduced 2.34%
12,508 $5.16 Million
Q2 2021

Aug 09, 2021

BUY
$294.17 - $371.65 $1.35 Million - $1.71 Million
4,600 Added 56.04%
12,808 $4.74 Million
Q1 2021

May 13, 2021

SELL
$249.67 - $299.48 $24,967 - $29,948
-100 Reduced 1.2%
8,208 $2.38 Million
Q3 2020

Nov 09, 2020

BUY
$175.56 - $226.45 $1.46 Million - $1.88 Million
8,300 Added 103750.0%
8,308 $1.88 Million
Q4 2019

Feb 12, 2020

SELL
$126.05 - $152.76 $4.16 Million - $5.05 Million
-33,037 Reduced 99.98%
8 $1,000
Q3 2019

Nov 12, 2019

SELL
$125.07 - $143.67 $25,014 - $28,733
-200 Reduced 0.6%
33,045 $4.37 Million
Q2 2019

Aug 16, 2019

SELL
$123.4 - $148.55 $7.47 Million - $8.99 Million
-60,514 Reduced 64.54%
33,245 $4.72 Million
Q1 2019

May 13, 2019

SELL
$104.82 - $146.73 $715,186 - $1 Million
-6,823 Reduced 6.78%
93,759 $13.6 Million
Q4 2018

Feb 05, 2019

BUY
$105.09 - $137.23 $852,279 - $1.11 Million
8,110 Added 8.77%
100,582 $11.4 Million
Q3 2018

Nov 07, 2018

SELL
$112.11 - $134.54 $1.74 Million - $2.09 Million
-15,516 Reduced 14.37%
92,472 $12.4 Million
Q2 2018

Aug 10, 2018

SELL
$102.37 - $117.25 $747,915 - $856,628
-7,306 Reduced 6.34%
107,988 $12.1 Million
Q1 2018

May 08, 2018

SELL
$98.19 - $115.2 $618,597 - $725,760
-6,300 Reduced 5.18%
115,294 $12.3 Million
Q4 2017

Feb 13, 2018

BUY
$100.43 - $118.09 $3.87 Million - $4.55 Million
38,515 Added 46.36%
121,594 $13.3 Million
Q3 2017

Nov 20, 2017

SELL
$96.72 - $109.26 $1.63 Million - $1.85 Million
-16,900 Reduced 16.9%
83,079 $8.97 Million
Q3 2017

Nov 07, 2017

BUY
$96.72 - $109.26 $1.8 Million - $2.03 Million
18,593 Added 22.85%
99,979 $10.8 Million
Q2 2017

Nov 20, 2017

BUY
N/A
81,386
81,386 $8.23 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.29B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.